Related Experiment Videos
[Guideline satisfying therapy for chronic heart failure]
1Klinik III für Innere Medizin, Universitätsklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. Uta.Hoppe@uni-koeln.de
Der Internist
|July 6, 2007
Summary
Standard treatments for systolic heart failure are effective, but evidence-based therapies for diastolic heart failure are lacking, leaving treatment largely empirical.
Area of Science:
- Cardiology
- Heart Failure Pathophysiology
- Pharmacotherapy
Context:
- Chronic heart failure presents as either systolic pump dysfunction or impaired diastolic ventricular filling.
- Current pharmacotherapy for systolic heart failure is well-established.
Purpose:
- To outline current therapeutic strategies for systolic heart failure.
- To highlight the limited evidence-based treatment options for diastolic heart failure.
Summary:
- Systolic heart failure management involves ACE inhibitors, beta-blockers, diuretics, and potentially aldosterone antagonists or AT1 receptor blockers.
- Biventricular pacing can improve symptoms and prognosis in severe systolic heart failure with cardiac dyssynchrony.
- Diastolic heart failure treatment relies primarily on empirical approaches due to a lack of clinical trial data.
Impact:
- Evidence-based treatments significantly reduce morbidity and mortality in systolic heart failure.
- The absence of clinical trial results for diastolic heart failure necessitates further research.
- Current therapeutic strategies for diastolic heart failure remain largely empirical, indicating a need for improved treatment guidelines.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...